Barclays upgraded CVS Health Inc (NYSE:CVS) on higher Pharmacy & Consumer Wellness (PCW) estimates as headwinds are offset by ...

CVS Health (CVS) stock gained as Barclays upgraded the company, citing a compelling path to margin recovery in its Medicare ...

Sixty-two percent of people currently enrolled in Medicare Advantage plans that cover prescription drugs are covered by plans ...

Medicare Advantage plans are changing their quality ratings, with the Centers for Medicare & Medicaid Services (CMS) ...

Stock in the healthcare provider Humana came under pressure again on Friday after the U.S. government released quality ...

CVS risks losing customers and revenue if it splits up its vertically integrated business segments, which includes health ...

Discover why TD Cowen sees 35% upside in CVS Health stock, driven by Medicare Advantage improvements and bullish technical ...

Read More Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by ...

CVS is reportedly conducting a strategic review and weighing options for separating some of the company’s businesses.

Medicare Advantage plans are government Medicare benefits provided through for-profit insurers, so plan terms can — and do — change ...

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...